4.3 Article

Hydralazine-Induced Pulmonary-Renal Syndrome: A Case Report

Journal

AMERICAN JOURNAL OF THERAPEUTICS
Volume 19, Issue 4, Pages E136-E138

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MJT.0b013e3181ed838c

Keywords

hydralazine vasculitis; hydralazine pulmonary-renal syndrome; drug-induced vasculitis; hydralazine pulmonary hemorrhage; hydralazine glomerulonephritis

Ask authors/readers for more resources

Drug-induced lupus erythematosus differs in its manifestation from drug-induced vasculitis. The former is associated with characteristic symptoms that improve following discontinuation, whereas the latter is predominantly an antineutrophil cytoplasmic antibody (ANCA) positive small vessel vasculitis involving the kidneys, skin, and lungs. We present a case of advanced disease in an elderly Caucasian woman requiring corticosteroids, and immunosuppressive therapy, who was on hydralazine for >2 years.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available